A New York Times editorial notes that two recent studies have found that older anti-psychotic drugs-used to treat schizophrenia and other mental health concerns-are just as effective as newer and far more expensive drugs in children ages 8 to 19. The studies, which looked at Zyprexa, Risperdal and an older generic drug, "found no clear difference… in relieving the symptoms of schizophrenia." There was one major difference, however: Side effects. On average, children taking Zyprexa and Risperdal gained anywhere from eight to 13 pounds along with "changes in cholesterol and insulin levels that can increase the risk of diabetes."
So, to recap: The newer drugs are far more expensive, no more helpful, and more likely to cause detrimental side effects.
